C07C 205/61
The carbon skeleton being further substituted by doubly-bound oxygen atoms
Official title: the carbon skeleton being further substituted by doubly-bound oxygen atoms
C07C205/61 (The carbon skeleton being further substituted by doubly-bound oxygen atoms) appears on 47 US grants and 12 published applications in this corpus.
Search patents in C07C- Granted patents
- 47
- Published applications
- 12
- Assignees
- 27
- Inventors
- 81
- Latest grant
- 10 Jan 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 4 | 0 |
| 1978 | 4 | 0 |
| 1979 | 7 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 7 | 0 |
| 1990 | 4 | 0 |
| 1991 | 3 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 1 | 0 |
| 2009 | 0 | 1 |
| 2010 | 1 | 1 |
| 2011 | 0 | 2 |
| 2012 | 1 | 0 |
| 2013 | 1 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 1 | 2 |
| 2017 | 2 | 2 |
| 2018 | 2 | 0 |
| 2019 | 0 | 1 |
| 2020 | 1 | 1 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Benzamide or benzamine compounds useful as anticancer agents for the treatment of human cancers10 Jan 2023US 11,548,894 B2Board of Regents, The University of Texas System
- Methods for preparing Nintedanib and intermediates thereof17 Nov 2020US 10,836,751 B2Shanghai Syncores Technologies Inc. Ltd.
- Benzamide or benzamine compounds useful as anticancer agents for the treatment of human cancers30 Oct 2018US 10,112,948 B2Board of Regents, The University of Texas System
- IRE-1α inhibitors29 May 2018US 9,981,901 B2Fosun Orinove Pharmatech, Inc.
- Synthetic analogues of xanthohumol11 Apr 2017US 9,617,213 B2Azienda Ospedaliera Arcispedale Santa Maria Nuova/IRCCS Instituto in Tecnologie Avanzate e Modelli Assistenziali in Oncologia
- Methods for preparing nintedanib and intermediates thereof13 Feb 2020US 2020/0048225 A1Shanghai Syncores Technologies Inc. Ltd.
- Benzamide or benzamine compounds useful as anticancer agents for the treatment of human cancers29 Aug 2019US 2019/0263820 A1Board of Regents, The University of Texas System
- IRE-1alpha INHIBITORS1 Jun 2017US 2017/0152206 A1MannKind Corporation
- Benzamide or benzamine compounds useful as anticancer agents for the treatment of human cancers27 Apr 2017US 2017/0114062 A1Board of Regents, The University of Texas System
- IRE-1alpha Inhibitors16 Jun 2016US 2016/0168116 A1MannKind Corporation
Most cited
By later US patents
- Certain 2-(2-substituted benzoyl)-1,3-cyclohexanediones42US 5,006,158 AICI Americas Inc. · 1991
- Benzamide derivatives35US 4,146,631 AMay & Baker Limited · 1979
- Certain 2-(2-substituted benzoyl)-1,3-cyclohexanediones18US 4,806,146 AStauffer Chemical Company · 1989
- Certain 2-(2-substituted benzoyl)-1,3-cyclohexanediones14US 4,946,981 AICI Americas Inc. · 1990
- Substituted benzoyl derivatives and selective herbicides14US 4,954,165 ANissan Chemical Industries, Ltd. · 1990